Madrigal reports real-world data showing Rezdiffra improves liver health measures through 12 months

Madrigal said real-world findings show improved liver health measures through 12 months among patients receiving Rezdiffra. The company will present 13 abstracts at AASLD’s The Liver Meeting, including findings from a dataset of more than 12,000 patients.